Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000, the waning days of the dot-com era. . . . → Read More: Infographic – U.S. Venture Funds Near 20-Year Highs
|
|||||
|
|
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis 
The world’s five leading technology enterprises are acquiring more companies and with more money in recent years than before. . . . → Read More: Infographic – Top Tech Acquisition Timeline 
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds  Comments are closed  Finance  biomedical, biotechnology, cancer, equity, Europe, genomics, investment, licensing, life sciences, manufacturing, pharmaceuticals, university, venture capital 
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, Japan, licensing, manufacturing, pharmaceuticals, stem cells, university, venture capital 
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, investment, IPO, life sciences, mathematics, medical device, pharmaceuticals, physical sciences 
A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications but with an architecture it says can avoid memory logjams. . . . → Read More: A.I. Chip Start-Up Raises $23M in Early Funds Comments are closed Finance, New products computer science, engineering, entrepreneurs, equity, investment, Israel, mathematics, physical sciences, semiconductors, software, venture capital 
A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies. . . . → Read More: Company Launches Attacking Cancer Proteins, Lands $67M One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital 
Root Robotics, a developer of robots that teach coding to school children, is now part of the consumer and educational robotics company iRobot Corp. . . . → Read More: Educational Robotics Spin-Off Company Acquired Comments are closed Finance, Intellectual property computer science, engineering, entrepreneurs, investment, licensing, mathematics, merger, physical sciences, robotics, software, university 
A university spin-off company is receiving a foundation grant to advance its Crispr technology targeting RNA to treat a form of muscular dystrophy. . . . → Read More: Foundation Supports Muscular Dystrophy RNA Therapy Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, grant, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||